Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus-Reference-Cited by-同舟云学术

Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus

Published:2002-10 Issue:1 Volume:56 Page:61-72
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Evers David L,Komazin Gloria,Shin Dongjin,Hwang Debbie D,Townsend Leroy B,Drach John C

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference52 articles.

1. Interaction of the herpes simplex virus type 1 packaging protein UL15 with full-length and deleted forms of the UL28 protein;Abbotts;J. Gen. Virol.,2000

2. Cytomegalovirus;Alford,1993

3. Bender, W., Reefschlaeger, J., Eckenberg, P., Goldmann, S., Harter, M., Hallenberger, S., Trappe, J., Weber, O., 1999. Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe. International Patent WO 99/37291.

4. What is synergy;Berenbaum;Pharm. Rev.,1989

5. Biron, K.K., 1995. Personal communication.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of the drug maribavir according to clinical studies;Clinical Medicine (Russian Journal);2024-05-07

2. Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers;Pharmaceutics;2023-11-27

3. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20

4. Anti-inflammatory and Antioxidant Activity Screening for New Steroidal Schiff Bases;MOROC J CHEM;2023

5. New Perspectives on Antimicrobial Agents: Maribavir;Antimicrobial Agents and Chemotherapy;2022-09-20